Short Description GenSight Biologics develops mitochondrial gene therapy to support healthy longevity.
Description GenSight Biologics is a biotechnology innovator targeting the fundamental mechanisms of aging through mitochondrial gene therapy. The company leverages advancements in gene therapy and collaborates with leading institutions to translate cutting‑edge science into practical interventions. By focusing on science‑backed solutions, GenSight Biologics aims to extend healthspan and improve quality of life across the globe.